North South Ventures

North South Ventures is a cross-border venture capital firm investing in early-stage healthcare companies. Co-located in prominent academic medical centers, including Stanford/UCSF and the University of Toronto, the firm leverages its strategic locations to identify and support innovative healthcare startups. The team has invested in over 350 medical portfolio companies, contributing to more than 40 FDA approvals in the biotech, medical device, and digital health/AI sectors, with cumulative funding exceeding $4 billion and facilitating three multi-billion-dollar IPOs since 2012. Their investment strategy focuses on companies that aim to significantly improve patient health and enhance the performance of healthcare systems. They assess the founders' mix of qualities alongside their motivations for solving a particular problem. The problem itself must have a vast impact and market potential. They look for solid intellectual property or patents that can secure the company's competitive advantage over time while ensuring the product is better than existing market options. It's essential that the startup provides robust data to support its strategies. Regulatory and legal compliance is thoroughly evaluated to ensure no future barriers to market entry. They pick companies that are well-informed about their regulatory obligations and clear on the pathway to approvals. With a team possessing expertise in medicine, science, healthcare innovation, and software engineering, along with experience in investing, entrepreneurship, and operations across startups to multi-billion-dollar enterprises, North South Ventures is uniquely positioned to identify and support promising new ventures in healthtech and biotech. Their approach combines deep industry knowledge with a commitment to advancing healthcare through strategic investments.